SAHPRA and partners successfully complete second cohort of Clinical Assessors short course
The South Africa Health Products Regulatory Authority (SAHPRA) has announced the successful completion of the second cohort of graduates who participated in a 12-week course for Clinical Assessors within African Regulatory Agencies. The course was developed to address the skills gap in regulatory sciences in Africa and was attended by participants from five regulatory agencies. The course was accredited by The University of Witwatersrand and was developed in collaboration with Pharmacometrics Africa and The Department of Pharmacy and Pharmacology at the University of Witwatersrand. This course will pave the way for future success and growth in the field of regulatory sciences in Africa.
Recent Posts
Merck Oncology Advancements Highlight Long-Term Data and Pipeline Progress at ASCO 2026
Merck oncology advancements continue to deliver meaningful progress for patients. New long-term data from multiple trials highlight sustained survival benefits across lung cancer, breast cancer, melanoma, and other tumor types. These advancements will feature prominently at the 2026 American S...
Marstacimab Cost-Effectiveness Analysis in Hemophilia Treatment: A Portuguese Assessment
The public assessment report for Hympavzi (marstacimab) in Portugal concludes that the product offers no added therapeutic value relative to recombinant factor VIII concentrates and emicizumab in patients aged 12 years and older weighing at least 35 kg with severe hemophilia A without factor VIII...
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer Treatment
NICE Pembrolizumab recommendation offers a major advance for adults with resectable locally advanced head and neck squamous cell carcinoma. This update provides an evidence-based overview of the final draft guidance issued by NICE recommending pembrolizumab, within its marketing authorisation, fo...